Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-27
2008-10-28
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S492000
Reexamination Certificate
active
07442693
ABSTRACT:
There is provided novel diazepines that function as agonists at the melanocortin 4 receptor and as agonists at the melanocortin 1 receptor, pharmaceutical compositions containing them, methods for their use in treatment, and processes for their preparation.
REFERENCES:
patent: 2003/0220324 (2003-11-01), Fotsch et al.
patent: WO95/28391 (1995-10-01), None
patent: WO96/11940 (1996-04-01), None
patent: WO00/33658 (2000-06-01), None
patent: WO02/070511 (2002-09-01), None
Tyle, Iontophoretic Devices for Drug Delivery, Pharm. Res. 3(6):318-326 (1986).
Sammond Douglas McCord
Sherrill Ronald George
Speake Jason Daniel
Szewczyk Jerzy Ryszard
Deppenbrock Bonnie L.
Kifle Bruck
SmithKline Beecham Corporation
LandOfFree
Diazepine compounds as ligands of the melanocortin 1 and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diazepine compounds as ligands of the melanocortin 1 and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazepine compounds as ligands of the melanocortin 1 and/or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3996167